2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

2024 ASCO® Annual Meeting Insights Hub
A

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanoma"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Allison Betof Warner
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Allison Betof Warner
190 views
June 11, 2024

Chapters

Overview of Cell Therapy in Melanoma

00:00

TILs & Engineered TCR T Cells Explained

00:54

Clinical Trials & Toxicity in TCR T Cells

04:09

Promising Results from PRAME Targeting TCR

07:03

Early Data & Potential of CAR T Cells

10:56

Key Takeaways & Future of Cell Therapy

14:15

Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

19:05
Deciphera

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik
Skin
05:27

ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes…

2024 ASCO® Annual Meeting Insights Hub

L. Burton

128 views
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

750 views
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

323 views
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

457 views
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

455 views
14:46

ASCO® 2024 Insights: "Safety & Efficacy of First-in-Class CXCR1/2 In…

2024 ASCO® Annual Meeting Insights Hub

S. Patel

60 views
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

274 views
02:57

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi vs. Adju…

ecancer

C. Blank

46 views
15:18

ASCO® 2024 Summary: "Adopting Cutting-Edge Cell Therapies in Melanom…

2024 ASCO® Annual Meeting Insights Hub

A. Betof Warner

190 views
03:12

ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immedi…

ecancer

A. Hauschild

37 views
09:13

ASCO® 2024 Insights: "QoL Data With Neoadjuvant Ipi & Nivo in Resect…

2024 ASCO® Annual Meeting Insights Hub

J. Lijnsvelt

55 views
03:36

ASCO® 2024 Insights: "PIVOTAL Study - Daromun vs. Immediate Surgery …

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

65 views
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

386 views
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

261 views
06:48

ASCO® 2024 Insights: "SCOPE Trial - Efficacy & Safety of SCIB1 Vacci…

2024 ASCO® Annual Meeting Insights Hub

H. Shaw

21 views
14:01

ASCO® 2024 Insights: "Macroscopic Stage III Melanoma and Immunothera…

2024 ASCO® Annual Meeting Insights Hub

H. Kluger

123 views
20:16

ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in Systemic T…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

185 views
11:33

ASCO® 2024 Summary: "PD-1-Refractory Advanced Melanoma - Getting to …

2024 ASCO® Annual Meeting Insights Hub

M. Mckean

145 views
09:25

ASCO® 2024 Insights: "NEO-TIM Trial - Combination or Sequence of Vem…

2024 ASCO® Annual Meeting Insights Hub

P. Ascierto

39 views
09:31

ASCO® 2024 Insights: "Roginolisib, an Oral, Highly Selective and All…

2024 ASCO® Annual Meeting Insights Hub

A. Di Giacomo

37 views
12:22

ASCO® 2024 Insights: "KEYNOTE-942 Trial - 3-Year Update on mRNA-4157…

2024 ASCO® Annual Meeting Insights Hub

J. Weber

222 views
11:34

ASCO® 2024 Insights: "RELATIVITY-048 Trial - Efficacy and Safety of …

2024 ASCO® Annual Meeting Insights Hub

P. Ascierto

202 views
10:17

ASCO® 2024 Insights: "RegoMel Trial - Regorafenib in Patients With P…

2024 ASCO® Annual Meeting Insights Hub

I. Dirven

32 views
08:10

ASCO® 2024 Insights: "OBX-115, IL2-Sparing Engineered TIL Cell Thera…

2024 ASCO® Annual Meeting Insights Hub

R. Amaria

37 views
03:55

ASCO® 2024 Insights: "COMBI-AD Study - Dabrafenib + Trametinib in St…

2024 ASCO® Annual Meeting Insights Hub

A. Hauschild

526 views
01:52

ASCO® 2024 Insights: "Individualized Neoantigen Therapy mRNA-4157 (V…

2024 ASCO® Annual Meeting Insights Hub

M. Mckean

31 views
07:38

ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Treatme…

2024 ASCO® Annual Meeting Insights Hub

B. Doonan

40 views